Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan.
Scartozzi M, Mandolesi A, Giampieri R, Pierantoni C, Loupakis F, Zaniboni A, Galizia E, Giustini L, Silva RR, Bisonni R, Berardi R, Biagetti S, Menzo S, Falcone A, Bearzi I, Cascinu S.
Scartozzi M, et al. Among authors: giampieri r.
Int J Cancer. 2010 Oct 15;127(8):1941-7. doi: 10.1002/ijc.25193.
Int J Cancer. 2010.
PMID: 20099280